...
首页> 外文期刊>Beni-Suef University Journal of Basic and Applied Sciences >Physiochemical characterization of taste masking levetiracetam ion exchange resinates in the solid state and formulation of stable liquid suspension for pediatric use
【24h】

Physiochemical characterization of taste masking levetiracetam ion exchange resinates in the solid state and formulation of stable liquid suspension for pediatric use

机译:固态掩味左乙拉西坦离子交换树脂的理化特性及稳定的儿科用液体悬浮液配方

获取原文
   

获取外文期刊封面封底 >>

       

摘要

In the present work, an attempt has been made to mask the bitter taste of Levetiracetam using various ion-exchange resins such as Amberlite IRP69 and Duolite AP143. The physicochemical characteristics of the drug–resin complex in the solid state were studied. FT-IR studies revealed that there is no interaction between drug and resin. The DSC and XRD studies proved that the drug is in amorphous nature. Using the same concentration of resins, Xanthan gum as suspending agent in a liquid dosage form for pediatric use was formulated. Evaluation parameters such as drug content, sedimentation volume, re-dispersibility and viscosity of the prepared suspension were found to be satisfactory. The higher Zeta potential value indicates the stability of the suspension. Suspension prepared with Duolite AP 143 efficiently masks the bitter taste of Levetiracetam compared to Amberlite IRP69. From thein vitrodrug release, a formulation with 1:2 ratios of resin has shown the maximum release at the end of 90 minutes. The sustained effect is due to one of the properties of the resin. The release profile follows zero order kinetics. The results obtained in this work show that drug–resin complexes effectively masked the bitter taste of Levetiracetam while liquid formulation provides an easier way to administer and to overcome problems with noncompliance of pediatrics.
机译:在目前的工作中,已经尝试使用各种离子交换树脂例如Amberlite IRP69和Duolite AP143掩盖左乙拉西坦的苦味。研究了固态药物-树脂复合物的理化特性。 FT-IR研究表明,药物和树脂之间没有相互作用。 DSC和XRD研究证明该药物为无定形性质。使用相同浓度的树脂,配制黄原胶作为儿科用液体剂型的悬浮剂。发现制备的悬浮液的评价参数例如药物含量,沉淀体积,可再分散性和粘度是令人满意的。较高的Zeta电位值表明悬浮液的稳定性。与Amberlite IRP69相比,用Duolite AP 143制备的悬浮液可有效掩盖左乙拉西坦的苦味。从体外药物释放,具有1:2比例的树脂的制剂在90分钟结束时显示出最大释放。持续的作用归因于树脂的特性之一。释放曲线遵循零级动力学。这项工作获得的结果表明,药物-树脂复合物有效地掩盖了左乙拉西坦的苦味,而液体制剂提供了一种更容易管理和克服儿科不合格问题的方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号